Progress on Neoadjuvant Immunotherapy for Resectable Non-small Cell Lung Cancer

In recent years, there has been a consensus regarding the enhancement of prognosis in patients with advanced non-small cell lung cancer (NSCLC) through the utilization of immune checkpoint inhibitors (ICIs). Numerous clinical studies have also demonstrated the substantial value of immunotherapy for...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Chang QI, Panwen TIAN, Weimin LI
Formato:	Artigo
Idioma:	Chinês
Publicado em:	Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2024-02-01
coleção:	Chinese Journal of Lung Cancer
Assuntos:	lung neoplasms neoadjuvant therapy immune checkpoint inhibitors perioperative period resectable non-small cell lung cancer
Acesso em linha:	http://dx.doi.org/10.3779/j.issn.1009-3419.2024.102.06
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!